Modulation of the Endocannabinoid System in Cardiovascular Disease-Reference-Cited by-同舟云学术

Modulation of the Endocannabinoid System in Cardiovascular Disease

Published:2008-10 Issue:4 Volume:52 Page:601-607
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Pacher Pál¹,Mukhopadhyay Partha¹,Mohanraj Rajesh¹,Godlewski Grzegorz¹,Bátkai Sándor¹,Kunos George¹

Affiliation:

1. From the Sections on Oxidative Stress Tissue Injury (P.P., P.M., R.M.) and Neuroendocrinology (G.G., S.B., G.K.), Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Md.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference72 articles.

1. Evidence for novel cannabinoid receptors

2. Cannabinoid receptors and endocannabinoids: Evidence for new players

3. The Endocannabinoid System as an Emerging Target of Pharmacotherapy

4. Targeting the endocannabinoid system: to enhance or reduce?

5. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein–Cannabinoid Type 1 Receptor Double Knockout Animals;International Journal of Molecular Sciences;2024-09-02

2. Cardiovascular (side) effects of cannabis;Wiener klinische Wochenschrift;2024-08-07

3. Stimuli-triggered pollen-inspired micro/nanorobots for advanced therapeutics;Nano Today;2024-08

4. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02

5. Construction and optimization of multi-platform precision pathways for precision medicine;Scientific Reports;2024-02-21